Abstract: Artificial intelligence is capable of reducing high costs in drug research and development as it finds solutions faster and with precision. MedAI implements AI-driven solutions for the development of therapeutic antibodies, as bio-drugs are used in an increasing number of pathologies, including oncology.Summary: Protein/Antibody drug discovery and development is the process of identifying new therapeutic antibodies to combat different diseases. These antibody therapeutics can become in a number of different formats, such as full length antibodies, bispecific antibodies, antibody fragments, and more.References: https://aimed.protheragen.com/protein-antibody-development.html
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
COVID-19 Related VLP Products
“Heta compiler” is a framework for the development and management of Quantitative Systems Pharmacology modeling platforms
Practical Identifiability Analysis of QSP Models with LikelihoodProfiler
Ivan Borisov, Evgeny Metelkin